Diagnosis
Hypoparathyroidism
Underproduction of PTH resulting in hypocalcemia, hyperphosphatemia, and neuromuscular irritability.
Etiology
Cause [hap]
Postsurgical: thyroid, parathyroid, larynx surgery (78%, most common) [1ug][hap]
Autoimmune
Autoimmune polyglandular syndrome-1
Isolated autoimmune hypoparathyroidism
Infiltrative
Granulomatous disease
Sarcoidosis
Amyloidosis
Metastatic cancer
Riedel struma
HIV
Destructive
Radiation
Metal deposition
Wilson’s disease (copper)
Hemochromatosis (iron)
Transfusion dependence (iron)
Aluminum toxicity
Metabolic causes
Hypermagnesemia
Hypomagnesemia
Burn injury
Fetal exposure to retinoids, alcohol or hyperglycemia or maternal hypercalcemia
Toxic agents: Asparaginase, Ethiofos, immune checkpoint inhibitors
Genetic disorders: DiGeorge Sequence; TBX; CHARGE syndrome, HDR syndrome (Barakat syndrome); Sanjad-Sakati syndrome, and Kenny-Caffey syndrome; Smith-Lemli-Opitz syndrome
Mitochondrial disorders: Kearns-Sayre syndrome; Pearson Marrow-Pancreas syndrome; MELAS syndrome
Idiopathic
Pathophysiology [soa]
Calcium homeostasis is regulated by:
Parathyroid hormone (PTH)
Vitamin D metabolites
Calcitonin
The mechanism control calcium transport in bone, kidneys, and the GI tract
Hypoparathyroidism --> PTH fail to rise in response to hypocalcemia --> no mobilization of the skeleton or increase in renal resorption --> hypocalcemia
Complications [soa]
Kidney failure
Kidney stones
Cataracts
Cognitive dysfunction
Cardiac arrhythmia
Anxiety
Depression
Epidemiology
Incidence per 100.000 [3tz][29e][knq][hap][iqw][gdk][nei][1ug]
Prevalence per 100.000 [3tz][29e][knq][hap][iqw][gdk][nei][1ug]
Symptoms & findings
Symptoms
Anxiety, Arrhythmia, Ataxia, Cardiac arrest, Coma, Confusion, Depression, Diaphoresis, Dysarthria, Dysphagia, Dyspnea, Hallucinations, Headache, Hoarseness, Hyperventilation, Muscle cramps, Paresthesia, Psychosis, Seizure, Stupor, Tachycardia, Tetany, Trousseau's sign, Wheezing
Clinical findings
Alkalosis, Chvostek's sign, Decreased PTH, Hypercalciuria, Hyperphosphatemia, Hypocalcemia, Hypokalemia, Hypomagnesemia, Inverted T wave, Prolonged QT interval
Anamneses
None listed.
Approach
Blood test: PTH, serum calcium, phosphate, magnesium, albumin, creatinine, fT4, TSH, vitamin D [iqw][soa]
24-hour urine calcium and creatinine
ECG
Renal ultrasound
Abdominal CT
Treatment
Acute onset with severe hypocalcemia: intravenous calcium administration [soa]
IV calcium bolus of 90-180 mg infused over 10-20 minutes with cardiac monitoring
Maintenance IV calcium infusion of 900 mg Ca in 1 L of saline at a rate of 50 mL/hr
Corrected calcium = measured total calcium + [0.8 x(4-measured serum albumin)]
Chronic hypoparathyroidism: [kdq]
Treatment goals:
Keep patients asymptomatic
Maintain the calcemia slightly below or in the lower normal range
Calciuria up to 4 mg/kg/day
Calcium supplementation:
Calcium carbonate 2.5-7.5 g/day
Calcium citrate 5-15 g/day
Vitamin D
Calcitriol 0.25-2 mcg/day
Cholecalciferol 10,000 - 100,000 UI/day
Magnesium supplementation: 250-1,000 mg/day
Phosphate binder: Sevelamer 800 mg x 3
Thiazide diuretic: 12,5-100 mg/day
Subcutaneous PTH injection 25-100 mcg/day
Differential diagnoses
Clostridium tetani, Hyperkalemia, Hyperphosphatemia, Hyperventilation, Hypocalcemia, Hypocapnia, Hypokalemia, Hypomagnesemia, Hypoparathyroidism, Milk-alkali syndrome
References
[1] Pasieka JL, Wentworth K, Yeo CT, Cremers S, Dempster D, Fukumoto S, Goswami R, Houillier P, Levine MA, Pasternak JD, Perrier ND, Sitges-Serra A, Shoback DM. Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review. J Bone Miner Res. 2022 Dec;37(12):2586-2601.
[2] Powers J, Joy K, Ruscio A, Lagast H. Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res. 2013 Dec;28(12):2570-6.
[3] Hans SK, Levine SN. Hypoparathyroidism. [Updated 2024 Feb 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441899/
[4] Bjornsdottir S, Ing S, Mitchell DM, Sikjaer T, Underbjerg L, Hassan-Smith Z, Sfeir J, Gittoes NJ, Clarke L BL. Epidemiology and Financial Burden of Adult Chronic Hypoparathyroidism. J Bone Miner Res. 2022 Dec;37(12):2602-2614.
[5] Vadiveloo T, Donnan PT, Leese GP. A Population-Based Study of the Epidemiology of Chronic Hypoparathyroidism. J Bone Miner Res. 2018 Mar;33(3):478-485.
[6] Cipriani C, Pepe J, Biamonte F, Manai R, Biondi P, Nieddu L, Cianferotti L, Brandi ML, Minisola S. The Epidemiology of Hypoparathyroidism in Italy: An 8-Year Register-Based Study. Calcif Tissue Int. 2017 Mar;100(3):278-285.
[7] Clarke BL, Brown EM, Collins MT, Jüppner H, Lakatos P, Levine MA, Mannstadt MM, Bilezikian JP, Romanischen AF, Thakker RV. Epidemiology and Diagnosis of Hypoparathyroidism. J Clin Endocrinol Metab. 2016 Jun;101(6):2284-99.
[8] Cianferotti L, Parri S, Gronchi G, Marcucci G, Cipriani C, Pepe J, Raglianti M, Minisola S, Brandi ML. Prevalence of Chronic Hypoparathyroidism in a Mediterranean Region as Estimated by the Analysis of Anonymous Healthcare Database. Calcif Tissue Int. 2018 Aug;103(2):144-150.
[9] Astor MC, Løvås K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedrebø BG, Svartberg J, Husebye ES. Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway. J Clin Endocrinol Metab. 2016 Aug;101(8):3045-53.
[10] Sakane EN, Vieira MCC, Vieira GMM, Maeda SS. Treatment options in hypoparathyroidism. Arch Endocrinol Metab. 2022 Nov 11;66(5):651-657.